Abstract:The ever-growing drug resistance problem worldwide highlights the urgency to discover and develop new drugs. Microbial natural products are a prolific source of drugs. Genome sequencing has revealed a tremendous amount of uncharacterized natural product biosynthetic gene clusters (BGCs) encoded within microbial genomes, most of which are cryptic or express at very low levels under standard culture conditions. Therefore, developing effective strategies to awaken these cryptic BGCs is of great interest for natural product discovery. In this study, we designed and validated a Transcription–Translation in One (TTO) approach for activation of cryptic BGCs. This approach aims to alter the metabolite profiles of target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding RNA polymerase β subunit) genes containing beneficial mutations for natural product production using a plug-and-play plasmid system. As a result, this approach bypasses the tedious screening work and overcomes the false positive problem in the traditional ribosome engineering approach. In this work, the TTO approach was successfully applied to activating cryptic BGCs in three Streptomyces strains, leading to the discovery of two aromatic polyketide antibiotics, piloquinone and homopiloquinone. We further identified a single BGC responsible for the biosynthesis of both piloquinone and homopiloquinone, which features an unusual starter unit incorporation step. This powerful strategy can be further exploited for BGC activation in strains even beyond streptomycetes, thus facilitating natural product discovery research in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00581</a>.Methods and materials, including strains, plasmids, chemicals, strain manipulation, cultivation and fermentation conditions, isolation and characterization of natural products from activated biosynthetic pathways, bioactivity assay, genome sequencing, gene overexpression and gene deletions (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00581/suppl_file/cb0c00581_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Activation and Characterization of Lanthomicins A–C by Promoter Engineering in Streptomyces chattanoogensis L10

Activation of Cryptic Antibiotic Biosynthetic Gene Clusters Guided by RNA-seq Data from Both Streptomyces Ansochromogenes and ΔwblA

Identification of a Bioactive 51-Membered Macrolide Complex by Activation of a Silent Polyketide Synthase in Streptomyces Ambofaciens

A Versatile Transcription–Translation in One Approach for Activation of Cryptic Biosynthetic Gene Clusters

Identification of the Biosynthetic Gene Cluster for the Anti-Mrsa Lysocins Through Gene Cluster Activation Using Strong Promoters of Housekeeping Genes and Production of New Analogs in Lysobacter Sp. 3655

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

Activation And Characterization Of A Cryptic Polycyclic Tetramate Macrolactam Biosynthetic Gene Cluster

Activation of a Silent Gene Cluster from the Endophytic Fungus Talaromyces sp. Unearths Cryptic Azaphilone Metabolites

OSMAC-Based Discovery and Biosynthetic Gene Clusters Analysis of Secondary Metabolites from Marine-Derived Streptomyces globisporus SCSIO LCY30

Eliciting the silent lucensomycin biosynthetic pathway in Streptomyces cyanogenus S136 via manipulation of the global regulatory gene adpA

Activation of Anthrachamycin Biosynthesis in Streptomyces Chattanoogensis L10 by Site-Directed Mutagenesis of Rpob

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

Mining public genomic databases for novel lanthipeptides: a case study on Bacillus amyloliquefaciens

Genome Sequencing of Streptomyces olivaceus SCSIO T05 and Activated Production of Lobophorin CR4 via Metabolic Engineering and Genome Mining

A Regulator Based “Semi-Targeted” Approach to Activate Silent Biosynthetic Gene Clusters

Production of chain-extended cinnamoyl compounds by overexpressing two adjacent cluster-situated LuxR regulators in Streptomyces globisporus C-1027

Activation, Structure, Biosynthesis and Bioactivity of Glidobactin‐like Proteasome Inhibitors from Photorhabdus laumondii

Recent Advances in Silent Gene Cluster Activation in Streptomyces

Engineered Streptomyces Lividans Strains for Optimal Identification and Expression of Cryptic Biosynthetic Gene Clusters

The Genomic-Driven Discovery of Glutarimide-Containing Derivatives from Burkholderia gladioli

Discovery of antimicrobial peptides clostrisin and cellulosin from Clostridium: insights into their structures, co-localized biosynthetic gene clusters, and antibiotic activity